Is Mylan Off Base About Perrigo Prospects?
This article was originally published in The Pink Sheet Daily
The company is confident it can take over its generic target, but analysts, management and investors seems to lack the same conviction. FTC and state court rulings remove additional roadblocks.
Register for our free email digests: